Laboratory-Related Outcomes in Healthcare (Beckman Conference) (Clinical Report) Laboratory-Related Outcomes in Healthcare (Beckman Conference) (Clinical Report)

Laboratory-Related Outcomes in Healthcare (Beckman Conference) (Clinical Report‪)‬

Clinical Chemistry 2001, August, 47, 8

    • 2,99 €
    • 2,99 €

Description de l’éditeur

Medical tests are central to modern medicine and require better characterization than has been the norm in the past. Tests must be characterized in several important ways (Table 1). Conceptually, the first step is to determine the analytical features of a new test. Clinical chemists have focused on (and are the traditional experts on) analytical features: precision, accuracy (or "trueness"), detection limits, linearity, interferences, and so forth. This focus is clearly evident from the "Information for Authors" of Clinical Chemistry (1), and articles in this Journal and elsewhere have exemplified the high standards of clinical chemists in defining the analytical performance of tests. Clinical chemists have also been active in other areas of test evaluation. They are among the foremost pioneers in the characterization of nonanalytical factors related to tests, including within- and between-person biological variation. In recent years, clinical chemists and clinical epidemiologists have stressed the need to improve the characterization of the diagnostic accuracies of tests (2,3). Indeed, the "Information for Authors" of Clinical Chemistry (1) now contains a checklist (3) of items to include in studies of diagnostic accuracy. By contrast, neither clinical chemists nor others have focused as intently on studies of the clinical usefulness of tests.

GENRE
Science et nature
SORTIE
2001
1 août
LANGUE
EN
Anglais
LONGUEUR
18
Pages
ÉDITIONS
American Association for Clinical Chemistry, Inc.
TAILLE
177
Ko

Plus de livres par Clinical Chemistry

Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998
Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report) Distribution of Adiponectin, Leptin, And Metabolic Correlates of Insulin Resistance: A Longitudinal Study in British Children; 1: Prepuberty (Earlybird 15) (Endocrinology and Metabolism) (Clinical Report)
2008
The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome. The MALDI-TOF Mass Spectrometric View of the Plasma Proteome and Peptidome.
2006
Interlaboratory Comparison of Fetal Male DNA Detection from Common Maternal Plasma Samples by Real-Time Pcr (Molecular Diagnostics and Genetics) Interlaboratory Comparison of Fetal Male DNA Detection from Common Maternal Plasma Samples by Real-Time Pcr (Molecular Diagnostics and Genetics)
2004
Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry) Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry)
2008
Association of Increased Ferritin with Premature Coronary Stenosis in Men (Lipids, Lipoproteins, And Cardiovascular Risk Factors) Association of Increased Ferritin with Premature Coronary Stenosis in Men (Lipids, Lipoproteins, And Cardiovascular Risk Factors)
2001